dermatology

April Clinical Considerations for NP's, PAsIn this month's Clinical Considerations, we look at handling the difficult patient, how to improve our diagnostic skills and the latest psoriasis drug approval.
New vistas in skin cancer careGenetic profiling is valuable in both diagnosis and prognosis of skin cancer. Hedgehog inhibitors and (superficial radiation therapy) SRT are strong contenders for treating nonmelanoma skin cancer. Advances in targeted therapies and biologics are part of the new wave of melanoma treatments.
Surgical management of melanomaAll surgical management of melanoma is defined by Breslow thickness. For melanoma less than 1 mm in thickness, typically a SLNB is not required. Future imaging devices may better delineate the extent and depth of the tumor in vivo.
Consolidation: What it looks like in dermatologyConsolidation is occurring throughout healthcare. An expert talks about what it means to practicing dermatologists.
The big squeezeLimited provider networks are cutting more than costs; these narrow networks are cutting dermatologists. One expert shares insight on what derms need to know.
Building a patient education programPatient education can be a powerful tool that complements your expertise and boosts patient engagement.
Hormonal therapies effective for acneHormonal therapies are an effective strategy to improve acne in women but some of these treatments, including birth control pills, are not commonly prescribed.
Crazy patient stories and how I deal with themNorman Levine, M.D., believes that acquiring a patient's full history isn't always as helpful as physicians make them out to be, and in fact, can occasionally be harmful.
Creating the virtual HS multispecialty clinicExpert dermatologist describes how to create the virtual multispecialty clinic to address the complex needs of hidradenitis suppurativa.
Nonablative technologies and the HS patientNonablative lasers, which are essentially modified hair removal lasers, offer treatment benefits for HS patients with stage 1 or stage 2 disease, according to dermatologist.